DNA Vaccines
VGX Pharmaceuticals Announces DNA Vaccines License Agreement with University of Pennsylvania
Published in Hepatitis Weekly, May 7th, 2007
VGX Pharmaceuticals Inc. (VGX) announced that it has signed a license agreement with the University of Pennsylvania covering novel DNA Vaccines and Therapeutics. Under the terms of the agreement VGX will have exclusive worldwide rights to develop a number of DNA plasmids and constructs with potential for the treatment and/or prevention of HIV, HCV, HPV and Influenza. This new agreement broadens the existing relationship between the two organizations. VGX was founded as a start-up in 2000 based on technology licensed from the University of Pennsylvania. VGX has previously licensed a number of product candidates and technology from the University of Pennsylvania and currently sponsors...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-05-07)
More Articles from Hepatitis Weekly
- Cancer Vaccines
Largest Healthcare Campaign for Asian and Pacific Islanders in the U.S. - HIV/AIDS
Gilead Sciences Announces First Quarter 2007 Financial Results - Sepsis
Iapyx Medical Introduces Stable-Line Family of Catheter Stabilization Devices Designed to Minimize Complications and Infections - Anemia Therapy
Research findings from Duke University, Duke Clinical Research Institute update understanding of anemia therapy - Hepatitis A Virus Epidemiology
Research on hepatitis A virus epidemiology published by scientists at Scientific Institute of Public Health - Hepatitis B Virus
Beijing Institute of Radiation Medicine reports research in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
